QMed, Inc.
QMED
$0.00
$0.000.00%
OTC PK
| 02/29/2008 | 11/30/2007 | 08/31/2007 | 05/31/2007 | 02/28/2007 | |
|---|---|---|---|---|---|
| Revenue | -36.10% | -35.51% | 65.99% | -16.56% | -67.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.10% | -35.51% | 65.99% | -16.56% | -67.52% |
| Cost of Revenue | -34.92% | -42.47% | 247.79% | 36.91% | -52.60% |
| Gross Profit | -37.47% | -25.68% | -121.05% | -57.82% | -76.24% |
| SG&A Expenses | -33.26% | -36.93% | -16.89% | -3.73% | 5.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.29% | -32.39% | 67.73% | 10.86% | -17.07% |
| Operating Income | 24.54% | 29.97% | -70.45% | -127.12% | -1,073.01% |
| Income Before Tax | -0.70% | 49.41% | -60.38% | -95.95% | -870.50% |
| Income Tax Expenses | 24.53% | 161.18% | -90.58% | -92.36% | -94.43% |
| Earnings from Continuing Operations | -0.75% | 48.96% | -56.74% | -81.88% | -1,253.54% |
| Earnings from Discontinued Operations | -208.78% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.97% | 20.96% | -136.30% | -260.34% | -2,323.30% |
| EBIT | 24.54% | 29.97% | -70.45% | -127.12% | -1,073.01% |
| EBITDA | 25.84% | 31.40% | -78.96% | -158.56% | -662.79% |
| EPS Basic | 13.93% | 21.83% | -134.65% | -259.93% | -2,247.75% |
| Normalized Basic EPS | 22.50% | 28.57% | -76.25% | -127.77% | -1,274.83% |
| EPS Diluted | 13.90% | 22.56% | -130.94% | -231.99% | -5,251.01% |
| Normalized Diluted EPS | 21.66% | 29.54% | -72.11% | -111.32% | -2,190.57% |
| Average Basic Shares Outstanding | 0.93% | 0.90% | 0.75% | 0.71% | 0.79% |
| Average Diluted Shares Outstanding | -0.70% | 2.54% | -0.63% | -3.30% | -5.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |